Volume 7, Number 4—August 2001
THEME ISSUE
West Nile Virus
West Nile Virus
Clinical Characteristics of the West Nile Fever Outbreak, Israel, 2000
Michal Y. Chowers*
, Ruth Lang*, Faris Nassar†, Debora Ben-David‡, Michael Giladi§, Eitan Rubinshtein‡, Avi Itzhaki¶, Josef Mishal#, Yardena Siegman-Igra§, Ruth Kitzes**, Neora Pick††, Zvi Landau‡‡, Dana Wolf§§, Hanna Bin¶¶, Ella Mendelson¶¶, Silvio D. Pitlik##, and Miriam Weinberger##
, Ruth Lang*, Faris Nassar†, Debora Ben-David‡, Michael Giladi§, Eitan Rubinshtein‡, Avi Itzhaki¶, Josef Mishal#, Yardena Siegman-Igra§, Ruth Kitzes**, Neora Pick††, Zvi Landau‡‡, Dana Wolf§§, Hanna Bin¶¶, Ella Mendelson¶¶, Silvio D. Pitlik##, and Miriam Weinberger##
Table 2
Laboratory abnormalities, on admission, in hospitalized patients with West Nile fever
| Laboratory results | No. (%) |
|---|---|
| Hb <12 g/dL in F | 91/221(41.1) |
| Hb <13.5 g/dL in M | |
| WBC <4.8 K/mL | 19/220 (8.6) |
| WBC >10.8 K/mL | 79/220 (35.9) |
| PLT <140 K/mL | 33/221 (14.9) |
| SGOT >37 U/L | 36/200 (18) |
| Alkaline phosphatase | 41/197 (20.8) |
| >117 U/L | |
| Na <135 mEq/L | 72/216 (33.3) |
| K <3.5 mEq/L | 29/215 (13.5) |
| Urea >50 mg/dL | 39/213 (18.3) |
Abbreviations used in this table: n = abnormal results/available results; WBC = leukocyte count; PLT = platelets; SGOT = serum glutamic oxalacetic transaminase.
Page created: April 27, 2012
Page updated: April 27, 2012
Page reviewed: April 27, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.